You are here: Industry Insights > cancer

News List

Hikma rises on cancer generic deal with China’s Hansoh pharmaphorum
November 30, 2018
UK-listed Hikma Pharma has licensed an array of injectable cancer drugs from China’s Hansoh, sparking a rise in its share price....
Oncolytics Biotech Appoints CMO contractpharma
November 30, 2018
Oncolytics Biotech announced that Dr. Rita Laeufle, M.D., Ph.D., who has been working as a consultant for Oncolytics for the last four months, has been appointed as chief medical officer. Dr. Laeufle will oversee the clinical development plan for pelareo
RCGP calls for better access to cancer diagnostic tests pharmatimes
November 29, 2018
GP access to appropriate diagnostic tests in the community is currently amongst the lowest in Europe, a report by The Health Foundation has found.
Nuformix expands licensing agreement with NSB for NXP001 pharmaceutical-technology
November 29, 2018
Nuformix has expanded its licensing agreement with its Chinese licensing partner Newsummit Biopharma (NSB) for NXP001, which is being developed for cancer supportive care.....
DNAtrix, Valo Therapeutics Enter Strategic R&D Pact contractpharma
November 28, 2018
DNAtrix and Valo Therapeutics entered an exclusive R&D collaboration to develop enhanced vaccines using DNAtrix's clinical stage viruses and Valo's antigenic peptide technology.
Evelo, Merck Enter Clinical Trial Collaboration contractpharma
November 28, 2018
Evelo Biosciences has entered into a clinical trial collaboration agreement with Merck. The collaboration will evaluate EDP1503 in combination with KEYTRUDA® (pembrolizumab),
US approves first ever TRK inhibitor pharmatimes
November 28, 2018
Bayer and Loxo Oncology’s Vitrakvi has become the first ever TRK inhibitor to be approved in the US, having been cleared to treat advanced solid tumours harbouring an NTRK gene fusion.
Machavert Pharmaceuticals Unveils a New Bioactive Lipid Drug Candidate for Cancer Treatment pharmafocusasia
November 28, 2018
Machavert Pharmaceuticals, a drug development company focused on bioactive phospholipid therapeutics for the treatment of cancer......
NHS lags best performers in cancer care – report pharmaphorum
November 28, 2018
The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.
CBT, Bossan Enter Clinical Collaboration contractpharma
November 27, 2018
CBT Pharmaceuticals (CBT) and Zhejiang Bossan Pharmaceutical Co., Ltd (Bossan) have entered into a clinical collaboration and license agreement to develop their respective assets in combination with each other.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page